163 related articles for article (PubMed ID: 20883676)
1. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.
Iizuka N; Oka M; Sakaida I; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Yamashita S; Okita K; Sakata K; Karino Y; Toyota J; Ando E; Ide T; Sata M; Tsunedomi R; Tsutsui M; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Fujita Y; Hamamoto Y
Clin Chim Acta; 2011 Jan; 412(1-2):152-8. PubMed ID: 20883676
[TBL] [Abstract][Full Text] [Related]
2. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
3. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
Ishida H; Matsuo S; Inoue Y
Rinsho Byori; 2010 Nov; 58(11):1065-72. PubMed ID: 21229703
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
8. Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels.
Bertino G; Ardiri AM; Santonocito MM; Boemi PM
Panminerva Med; 2009 Jun; 51(2):133-4. PubMed ID: 19776714
[No Abstract] [Full Text] [Related]
9. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
Forner A; Reig M; Bruix J
Gastroenterology; 2009 Jul; 137(1):26-9. PubMed ID: 19482098
[No Abstract] [Full Text] [Related]
10. [High risk group for development of hepatocellular carcinoma].
Koike Y; Shiratori Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
[No Abstract] [Full Text] [Related]
11. [Biological markers of hepatocellular carcinoma].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
[TBL] [Abstract][Full Text] [Related]
12. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].
Yamashiki M; Kosaka Y
Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846
[No Abstract] [Full Text] [Related]
13. [Tumor markers for hepatocellular carcinoma].
Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
16. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
17. How many patients with HCC have normal des-gamma-carboxy prothrombin and alpha-fetoprotein levels?
Castelli A
Panminerva Med; 2009 Sep; 51(3):188. PubMed ID: 19859054
[No Abstract] [Full Text] [Related]
18. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
[TBL] [Abstract][Full Text] [Related]
19. [PIVKA-II high-sensitivity PIVKA-II].
Fujiyama S
Nihon Rinsho; 2001 Oct; 59 Suppl 6():349-55. PubMed ID: 11761970
[No Abstract] [Full Text] [Related]
20. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
